All 66 XPH (STATE STREET(R) SPDR(R) S&P(R) PHARMACEUTICALS ETF) Holdings
There are 66 XPH holdings. Top 10 companies weight: 24.19%.
Total Market Cap: $2.39T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (66 stocks) | +16.79% | 26.72 | 22.24 | 0.30 | +12.01% | +21.60% | 0.59 | ||||||||||
1 | CRNX | Crinetics Pharmaceuticals Inc | 3.71% | $83.87 | $8.84B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | 78 | -1.63% | $83 | +33.54% | 1.02 |
2 | DFTX | N/A | 2.98% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | MBX | Mbx Biosciences Inc | 2.97% | $60.14 | $2.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +14.73% | $69 | 0.00% | 1.44 |
4 | ELVN | Enliven Therapeutics Inc | 2.18% | $51.67 | $3.24B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +27.73% | $66 | +17.53% | 1.16 |
5 | ALMS | Alumis Inc | 2.18% | $27.98 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +43.32% | $40 | 0.00% | 0.87 |
6 | ATAI | Ataibeckley Inc | 2.15% | $7.19 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +75.10% | $13 | -15.80% | 1.41 |
7 | TRVI | Trevi Therapeutics Inc | 2.05% | $16.77 | $2.33B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 80 | +48.48% | $25 | +53.00% | 0.65 |
8 | MANE | Veradermics Inc | 2.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | AMLX | Amylyx Pharmaceuticals Inc | 2.00% | $17.45 | $1.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +39.83% | $24 | 0.00% | 1.14 |
10 | NUVB | N/A | 1.95% | $6.26 | $2.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.96% | $12 | -6.73% | 1.47 |
11 | EWTX | Edgewise Therapeutics Inc | 1.88% | $38.81 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +28.63% | $50 | +13.70% | 1.37 |
12 | NKTR | Nektar Therapeutics | 1.82% | $64.84 | $1.69B | Biotechnology | Healthcare | -24.01% | N/A | 34.01 | 0.31 | N/A | N/A | 75 | +136.35% | $153 | -23.76% | 1.81 |
13 | LGND | Ligand Pharmaceuticals Inc | 1.81% | $293.99 | $5.93B | Biotechnology | Healthcare | +26.59% | 37.91 | 34.01 | 1.53 | N/A | N/A | 80 | +5.89% | $311 | +18.82% | 0.96 |
14 | LQDA | Liquidia Corp Ordinary Shares | 1.81% | $77.08 | $6.87B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 323.20 | 20.12 | N/A | N/A | N/A | 75 | -3.67% | $74 | +97.89% | 1.11 |
15 | MAZE | Maze Therapeutics Inc | 1.81% | $28.37 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +120.48% | $63 | 0.00% | 0.87 |
16 | HROW | Harrow Inc | 1.81% | $44.45 | $1.60B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 312.50 | N/A | N/A | N/A | 75 | +52.42% | $68 | +42.56% | 1.72 |
17 | CORT | Corcept Therapeutics Inc | 1.74% | $91.57 | $9.35B | Biotechnology | Healthcare | -8.23% | 212.86 | 111.11 | 0.81 | N/A | N/A | 75 | +15.76% | $106 | +34.57% | 1.32 |
18 | OCUL | Ocular Therapeutix Inc | 1.73% | $8.71 | $2.18B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +211.02% | $27 | -7.24% | 1.29 |
19 | EYPT | Eyepoint Inc | 1.70% | $12.66 | $1.16B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 81 | +219.91% | $41 | +8.42% | 1.24 |
20 | AMRX | N/A | 1.70% | $17.50 | $5.44B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 54.57 | 6.30 | N/A | N/A | N/A | 87 | +4.29% | $18 | +29.69% | 0.89 |
21 | ELAN | Elanco Animal Health Inc | 1.69% | $25.13 | $13B | Drug Manufacturers - Specialty & Generic | Healthcare | -17.32% | N/A | 23.47 | 4.04 | N/A | N/A | 80 | +18.82% | $30 | -6.77% | 1.35 |
22 | PCRX | Pacira Biosciences Inc | 1.64% | $25.35 | $996M | Drug Manufacturers - Specialty & Generic | Healthcare | -47.75% | 191.22 | 8.74 | 11.21 | N/A | N/A | 58 | +17.04% | $30 | -15.40% | 0.31 |
23 | INDV | N/A | 1.63% | $39.12 | $5.08B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 25.96 | 13.28 | N/A | N/A | N/A | 83 | +29.93% | $51 | +30.59% | 0.71 |
24 | SUPN | Supernus Pharmaceuticals Inc | 1.61% | $47.42 | $2.77B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +33.91% | $64 | +11.35% | 0.49 |
25 | VTRS | Viatris Inc | 1.60% | $16.99 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 7.02 | 0.14 | N/A | N/A | 60 | +4.83% | $18 | +8.31% | 0.79 |
26 | BMY | Bristol-myers Squibb Co | 1.60% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
27 | COLL | Collegium Pharmaceutical Inc | 1.60% | $35.54 | $1.19B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 40.29 | 4.86 | N/A | N/A | N/A | 79 | +50.82% | $54 | +6.96% | 0.50 |
28 | WVE | Wave Life Sciences Ltd | 1.58% | $5.73 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +282.90% | $22 | -3.51% | 1.46 |
29 | JAZZ | Jazz Pharmaceuticals Plc | 1.58% | $243.47 | $15B | Biotechnology | Healthcare | N/A | N/A | 13.51 | 0.96 | N/A | N/A | 78 | +7.51% | $262 | +6.61% | 0.72 |
30 | JNJ | Johnson & Johnson | 1.57% | $248.94 | $595B | Drug Manufacturers - General | Healthcare | +11.59% | 22.09 | 21.74 | 4.95 | N/A | N/A | 70 | +8.44% | $270 | +11.07% | N/A |
31 | MRK | Merck & Co Inc | 1.57% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
32 | RPRX | Royalty Pharma Plc Class A | 1.57% | $57.30 | $25B | Biotechnology | Healthcare | N/A | 28.69 | 48.08 | 1.32 | N/A | N/A | 75 | +4.53% | $60 | +9.29% | 0.25 |
33 | LLY | Eli Lilly And Co | 1.54% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
34 | OMER | Omeros Corp | 1.54% | $9.63 | $747M | Biotechnology | Healthcare | N/A | 9.26 | 58.14 | 0.81 | N/A | N/A | 58 | +242.68% | $33 | -7.69% | 1.37 |
35 | OGN | Organon & Co Ordinary Shares | 1.53% | $13.49 | $3.54B | Drug Manufacturers - General | Healthcare | -35.81% | 14.33 | 5.09 | N/A | N/A | N/A | 40 | -16.60% | $11 | -11.49% | 0.85 |
36 | XERS | Xeris Biopharma Holdings Inc | 1.52% | $8.60 | $1.50B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 121.84 | 109.89 | N/A | N/A | N/A | 75 | +31.28% | $11 | +18.83% | 1.02 |
37 | ANIP | Ani Pharmaceuticals Inc | 1.50% | $77.72 | $1.69B | Drug Manufacturers - Specialty & Generic | Healthcare | +25.74% | 20.37 | 9.59 | 0.01 | N/A | N/A | 85 | +41.53% | $110 | +18.24% | 0.60 |
38 | HRMY | N/A | 1.49% | $33.50 | $2.02B | Biotechnology | Healthcare | N/A | 13.82 | 10.71 | N/A | N/A | N/A | 63 | +34.06% | $45 | +2.54% | 0.62 |
39 | PBH | Prestige Consumer Healthcare Inc | 1.49% | $50.41 | $2.34B | Drug Manufacturers - Specialty & Generic | Healthcare | +8.18% | 12.37 | 11.12 | 1.47 | N/A | N/A | 67 | +32.51% | $67 | -0.96% | 0.38 |
40 | PFE | Pfizer Inc | 1.47% | $24.75 | $141B | Drug Manufacturers - General | Healthcare | -6.35% | 11.65 | 8.58 | 0.09 | N/A | N/A | 58 | +16.32% | $29 | -4.84% | 0.38 |
41 | AXSM | Axsome Therapeutics Inc | 1.46% | $221.64 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +26.51% | $280 | +31.16% | 0.66 |
42 | INVA | Innoviva Inc | 1.44% | $21.28 | $1.62B | Biotechnology | Healthcare | +16.74% | 3.15 | 11.07 | 0.32 | N/A | N/A | 62 | +66.82% | $36 | +9.59% | 0.15 |
43 | TARS | N/A | 1.42% | $56.25 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +68.11% | $95 | +16.34% | 0.61 |
44 | ZTS | Zoetis Inc Class A | 1.39% | $76.20 | $31B | Drug Manufacturers - Specialty & Generic | Healthcare | +10.56% | 12.08 | 11.20 | 1.05 | N/A | N/A | 67 | +50.60% | $115 | -16.45% | 0.56 |
45 | BIOA | Bioage Labs Inc | 1.38% | $22.32 | $1.01B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +121.77% | $50 | 0.00% | 1.04 |
46 | ETON | Eton Pharmaceuticals Inc | 1.38% | $41.07 | $1.05B | Drug Manufacturers - Specialty & Generic | Healthcare | -38.49% | N/A | 62.50 | N/A | N/A | N/A | 75 | +19.92% | $49 | +48.38% | 0.86 |
47 | PRGO | Perrigo Co Plc | 1.38% | $10.59 | $1.40B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 5.06 | N/A | N/A | N/A | 65 | +55.81% | $17 | -22.18% | 0.77 |
48 | PAHC | Phibro Animal Health Corp Class A | 1.37% | $33.05 | $1.37B | Drug Manufacturers - Specialty & Generic | Healthcare | +15.27% | 13.83 | 13.83 | 0.03 | N/A | N/A | 50 | +37.97% | $46 | +8.29% | 1.16 |
49 | RAPP | Rapport Therapeutics Inc | 1.37% | $40.21 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +40.86% | $57 | 0.00% | 1.26 |
50 | ANRO | Alto Neuroscience Inc | 1.23% | $25.97 | $973M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +35.27% | $35 | 0.00% | 1.26 |
XPH (STATE STREET(R) SPDR(R) S&P(R) PHARMACEUTICALS ETF) Sector Allocation
HEALTHCARE
98.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%